Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


15.04.2019

2 Am J Pathol
3 Dig Dis Sci
2 Hepatology
1 J Gastroenterol Hepatol
1 J Hepatol
2 Lancet Gastroenterol Hepatol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. KENNEDY L, Hargrove L, Demieville J, Bailey J, et al
    Knockout of l-Histidine Decarboxylase (HDC(-/-)) Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.
    Am J Pathol. 2017 Dec 14. pii: S0002-9440(17)30615.
    PubMed     Text format     Abstract available

  2. CARPINO G, Cardinale V, Folseraas T, Overi D, et al
    Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis.
    Am J Pathol. 2017 Dec 14. pii: S0002-9440(17)30740.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  3. JOPSON L, Khanna A, Peterson P, Rudell E, et al
    Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
    PubMed     Text format     Abstract available

  4. OU Q, Weng Y, Wang S, Zhao Y, et al
    Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-kappaB Pathway.
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5268.
    PubMed     Text format     Abstract available

  5. ZHANG S, Gong Y, Xiao J, Chai Y, et al
    A COL1A1 Promoter-Controlled Expression of TGF-beta Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
    Dig Dis Sci. 2018 Jun 23. pii: 10.1007/s10620-018-5168.
    PubMed     Text format     Abstract available


    Hepatology

  6. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    PubMed     Text format     Abstract available

  7. CHEN YJ, Tsai CF, Wang YP, Lu CL, et al
    To the editor: Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30641.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  8. WATSON H, Guevara M, Vilstrup H, Gines P, et al
    Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.
    J Gastroenterol Hepatol. 2019 Apr 9. doi: 10.1111/jgh.14683.
    PubMed     Text format     Abstract available


    J Hepatol

  9. CABIBBO G, Celsa C, Calvaruso V, Petta S, et al
    Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
    J Hepatol. 2019 Apr 5. pii: S0168-8278(19)30221.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  10. SONNEVELD MJ, Brouwer WP, Chan HL, Piratvisuth T, et al
    Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study.
    Lancet Gastroenterol Hepatol. 2019 Apr 8. pii: S2468-1253(19)30087.
    PubMed     Text format     Abstract available

  11. TSENG TC, Shih YF, Liu CJ
    A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B.
    Lancet Gastroenterol Hepatol. 2019 Apr 8. pii: S2468-1253(19)30118.
    PubMed     Text format    


    PLoS One

  12. LIU C, Wang L, Xie H, Zhang L, et al
    The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection.
    PLoS One. 2018;13:e0206060.
    PubMed     Text format     Abstract available

  13. UCHIDA Y, Naiki K, Kouyama JI, Sugawara K, et al
    Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy.
    PLoS One. 2018;13:e0205600.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: